Each domain brief documents the in-vitro endpoints, handling requirements, and analytical documentation applied to that portion of the catalog. Every brief is available as a PDF.
Body-weight and adipose-tissue endpoints in preclinical models
Read brief →02Glucose homeostasis and beta-cell function research
Read brief →03Lipid profiles, blood pressure, and vascular inflammation surrogates
Read brief →04Resting metabolic rate and thermogenesis research
Read brief →05Hepatic steatosis, triglyceride handling, and liver-health surrogates
Read brief →06Central and peripheral feeding-behavior signaling
Read brief →07Obstructive sleep apnea and respiratory physiology surrogates
Read brief →08GLP-1, GIP, and glucagon receptor mechanism-of-action studies
Read brief →Every lot is released against a fixed identity and purity specification. Analytical records are retained on file and available on request for laboratory qualification purposes.
| Attribute | Method | Specification |
|---|---|---|
| Identity | LC-MS | Matches theoretical monoisotopic mass |
| Purity | RP-HPLC, 214 nm | ≥ 98.0 % area |
| Related substances | RP-HPLC | No single impurity > 1.0 % |
| Appearance | Visual | White to off-white lyophilized cake |
| Water content | Karl Fischer | Reported per lot |
| Endotoxin | LAL | Available on request |
| Lot | Released | Purity | Identity | Storage |
|---|---|---|---|---|
| R3-2411-A | 2024-11-08 | 99.2 % | Confirmed | −20 °C |
| R3-2502-C | 2025-02-19 | 98.7 % | Confirmed | −20 °C |
| R3-2506-B | 2025-06-03 | 99.4 % | Confirmed | −20 °C |
| R3-2511-D | 2025-11-27 | 98.9 % | Confirmed | −20 °C |
| R3-2604-A | 2026-04-14 | 99.1 % | Confirmed | −20 °C |
Per-lot analytical reports, chromatograms, and mass spectra can be issued to qualified laboratories. Reference the lot number in your request.
Request lot documentation →All figures shown are representative laboratory records for reference materials supplied For Research Purpose Only.